Glenmark Pharma has
disappointed the street by its first quarter numbers as consolidated net profit
fell by 62.5% year-on-year to Rs 78.3 crore in the quarter, which was far lower
than forecast of Rs 131 crore.
Consolidated net sales increased 19.8% to Rs 1,040 crore
from Rs 868 crore year-on-year, which was almost in-line with analysts'
expectations of Rs 1,028 crore.
The share rose just 0.36% to close at Rs 387.60 amid huge
volumes.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment